Comparison of Direct Medical Costs between Integrated Care with Palliative Care and Standard Treatment in Older Patients with Cancer
Main Article Content
Abstract
Integrated treatment with palliative care is a comprehensive approach addressing both disease management and symptom relief. It emphasizes holistic care and early palliative planning,enhancing the quality of life for patients with advanced cancer. Integrated treatment with palliative care is an approach that combines disease-targeted therapies with palliative interventions to improve patients quality of life. It is important for individuals with serious, chronic, or life-threatening illnesses to ensure that they receive comprehensive care that addresses both physical symptoms and psychosocial well-being. Evidence-based medicine strongly supports the benefits of early and continuous integration of palliative care into standard treatment. Previous studies found that patients with advanced cancer who received early palliative care reduced emergency visits, intensive care unit (ICU) admissions, and aggressive end-of-life interventions, and systematic reviews reported that integrated palliative care significantly improved suffering symptom management, psychosocial support,and satisfaction in cancer care. In contrast, standard treatment primarily focuses on disease management without a structured palliative care plan, which may impact patient expenses, particularly among older patients.However, studies on the costs of palliative care for older patients with cancer (aged ≥ 60 years) in Thailand remain limited. This study aimed to compare direct medical costs between older patients with cancer receiving integrated care with palliative care and those receiving standard treatment in the last six months before death. The definition of direct medical costs refers to the actual expenses incurred for medical services, treatments, and interventions directly related to patient care. These costs are essential in evaluating the economic impact of healthcare intervention. A retrospective analysis was conducted using data from patients with cancer aged 60 and older who died between January 1, 2016 and December 31, 2021. Clinical and cost data were systematically recorded in the Faculty of Medicine Ramathibodi Hospital's database and the hospital-based cancer registry. All cost values were adjusted for inflation to 2021 values. Descriptive statistics and multiple regression analyses were used to assess medical expenses while controlling for variables such as sex, age group,cancer type, and healthcare entitlement. The study included a total of 1,013 older patients with cancer,with 52.00% being male and an average age of 72.37 years. The most common causes of cancer-related deaths were lung cancer (20.40%),colorectal cancer (15.79%), and hepatobiliary cancers (10.90%). Regarding healthcare entitlements, the majority of patients were covered under the government employee healthcare scheme (56.86%), while the lowest proportion was covered under social security. Among the patients, 798 received standard treatment, while 215 received integrated palliative care. Receiving integrated palliative care had a significantly lower median number of hospital visits, including emergency department and inpatient admissions, compared to those receiving standard treatment (z = 3.04, p = .002; z = 2.54, p= .011). Regarding direct medical costs, patients who received integrated palliative care had total costs of 125,764.90 THB, 269,619.90 THB, and 362,806.00 THB at 1, 3, and 6 months before death, respectively. In contrast, those receiving standard treatment incurred higher costs of 258,476.00 THB, 376,494.80 THB, and 494,303.20 THB at the same time intervals. Cost reductions in the integrated care group were 44%, 28%, and 27% at 1, 3, and 6 months before death, respectively. Among patients covered under the government employee healthcare scheme, integrated care resulted in a cost reduction of 198,769.60 THB over six months compared to standard treatment. The findings confirm that older patients with cancer receiving integrated palliative care incur significantly lower hospital expenses than those receiving standard treatment (t = 4.40, p < .001). Patients under the government employee healthcare scheme had higher end-of-life medical costs than those under other schemes, likely due to more comprehensive coverage and access to medical services. However, although Thailand's universal health coverage system has included palliative care services in all healthcare schemes since 2002, this study found that only 20% of patients received integrated treatment with palliative care. This may be due to limitations in the number of palliative care personnel and insufficient awareness of the benefits of this type of care. This study concludes that integrated treatment with palliative care is a crucial component of healthcare for older patients with cancer, improving patient outcomes, enhancing quality of life,it also helps reducing medical costs. To enhance patient quality of life and reduce healthcare costs,policymakers and healthcare providers should expand access to integrated palliative care, ensuring that older patients with cancer benefit from a holistic and cost-effective approach to end-of-life care.
Keywords: Cancer patient, Medical Cost, Older adults, Palliative Care, Treatment expenses
Article Details

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
บทความ ข้อมูล เนื้อหา รูปภาพ ฯลฯ ที่ได้รับการตีพิมพ์ในรามาธิบดีพยาบาลสาร ถือเป็นลิขสิทธิ์ของวารสาร หากบุคคลหรือหน่วยงานใดต้องการนำทั้งหมดหรือส่วนหนึ่งส่วนใดไปเผยแพร่หรือเพื่อกระทำการใด ใด จะต้องได้รับอนุญาตเป็นลายลักษณ์อักษรจากรามาธิบดีพยาบาลสารก่อนเท่านั้น
References
Foundation of Thai Gerontology Research and Development Institute. Situation of the Thai elderly [Cited 2021 October 30]. Available from: https://thaitgri.org/?p=39772
Suwanrungruang K, Sangrajrang S, Buasom R. Cancer incident in Thailand. In: Rojanamatin J, Ukranun W,Supaatagorn P, Chiawiriyabunya I, Wongsena M,Chaiwerawattana A, et al., editors. Cancer In Thailand Vol X, 2016-2018. National Cancer Institute: 2021. p.4-65.
Bruera E, Yennurajalingam S. Palliative care in advanced cancer patients: how and when? Oncologist.2012;17(2):267-73.
Kamal AH BC, Casarett DJ, Currow DC, Dudgeon DJ,Higginson IJ. Standards, guidelines, and quality measures for successful specialty palliative care integration into oncology current approaches and future directions. J Clin Oncol. 2020;38(9):987-94.
Earle CC, Landrum MB, Souza JM, Neville BA, Weeks JC, Ayanian JZ. Aggressiveness of cancer care near the end of life: is it a quality-of-care issue? J Clin Oncol.2008;26(23):3860-6.
Chastek B, Harley C, Kallich J, Newcomer L, Paoli C,Teitelbaum A. Health care costs for patients with cancer at the end of life. JCO Oncol Prac. 2012;8(6S):75-80.
EJ. E. Cost savings at the end of life. What do the data show? JAMA. 1996;275(24):1907-14.
Yadav S, Heller IW, Schaefer N, Salloum RG, Kittelson SM, Wilkie DJ, et al. The health care cost of palliative care for cancer patients: a systematic review. Support Care Cancer. 2020;28(10):4561-73.
Reeve R, Srasuebkul P, Langton JM, Haas M, Viney R,Pearson SA, et al. Health care use and costs at the end of life: a comparison of elderly Australian decedents with and without a cancer history. BMC Palliat Care. 2017;17(1):1.
Drummond MF, Sculpher MJ, Claxton K, Stoddart GL, Torrance GW. Methods for the economic evaluation of health care programmes: Oxford university press; 2015
Gordon MJ, Le T, Lee EW, Gao A. Home palliative care savings. J Palliat Med. 2022;25(4):591-5.
Hui D, Hannon BL, Zimmermann C, Bruera E. Improving patient and caregiver outcomes in oncology:Team-based,timely, and targeted palliative care. CA Cancer J Clin.2018;68(5):356-76.
Triplett DP, LeBrett WG, Bryant AK, Bruggeman AR,Matsuno RK, Hwang L, et al. Effect of palliative care on aggressiveness of end-of-life care among patients with advanced cancer.pdf. 2017;13(9):e760-e9.Huang YT,Wang YW, Chi CW, Hu WY, Lin R, Jr., Shiao CC, et al.
Differences in medical costs for end-of-life patients receiving traditional care and those receiving hospice care:A retrospective study. PLoS One. 2020;15(2):e0229176.
Langton JM, Reeve R, Srasuebkul P, Haas M, Viney R,Currow D, et al. Health service use and costs in the last 6 months of life in elderly decedents with a history of cancer:a comprehensive analysis from a health payer perspective.Br J Cancer. 2016;114(11):1293-302.
May P, Garrido MM, Cassel JB, Kelley AS, Meier DE,Normand C, et al. Cost analysis of a prospective multi-site cohort study of palliative care consultation teams for adults with advanced cancer: Where do cost-savings come from?Palliat Med. 2017;31(4):378-86.
Jo M, Lee Y, Kim T. Medical care costs at the end of life among older adults with cancer: a national health insurance data-based cohort study. BMC Palliat Care 22, 76 (2023). https://doi.org/10.1186/s12904-023-01197-2
Schrijvers D, Cherny NI, Group EGW. ESMO clinical practice guidelines on palliative care: advanced care planning. Ann Oncol. 2014;25 Suppl 3:iii138-42.
Ferrell BR, Temel JS, Temin S, Alesi ER, Balboni TA,Basch EM, et al. Integration of palliative care Into standard oncology care: American society of clinical oncology clinical practice guideline update. J Clin Oncol.2017;35(1):96-112.
Hwang J, Shen J, Kim SJ, Chun SY, Kioka M, Sheraz F,et al. Ten-year trends of utilization of palliative care services and life-sustaining treatments and hospital costs associated with Patients with terminally Ill lung cancer in the United States from 2005 to 2014. Am J Hosp Palliat Care. 2019;36(12):1105-13.
Ho TH, Barbera L, Saskin R, Lu H, Neville BA, Earle CC. Trends in the aggressiveness of end-of-life cancer care in the universal health care system of Ontario, Canada.J Clin Oncol. 2011;29(12):1587-91.